Publications by authors named "Y Arase"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

79,364

Total Likes

1,734

Extended Reach

208,892

Social Features

4
L
Low serum potassium levels and risk of type 2 diabetes: the Toranomon Hospital Health Management Center Study 1 (TOPICS 1).
Y Heianza, S Hara, Y Arase, K Saito, K Totsuka, H Tsuji, S Kodama, S D Hsieh, N Yamada, K Kosaka

Diabetologia· April 2011

Videos about Article: user user

2 2

View All Article and Social Media Activity
A
Arrhythmias in Cronkhite-Canada Syndrome.
Ryuzo Deguchi, Takashi Ueda, Masaya Sano, Hirohiko Sato, Erika Teramura, Yoshitaka Arase

Intern Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Denosumab versus zoledronic acid for osteoporosis treatment in patients with primary biliary cholangitis (the DELTA Study): A multicenter, non-inferiority randomized trial.
Yoshitaka Arase, Tomomi Okubo, Taeang Arai, Masanori Abe, Tadashi Namisaki

Hepatol Commun· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Case of Unresectable Gastric Cancer Successfully Treated with Conversion Surgery After Immunotherapy Including Treatment.
Mika Ogimi, Ryuzo Deguchi, Erika Teramura, Takashi Ueda, Masashi Morimachi, Yoshitaka Arase

Tokai J Exp Clin Med· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the COVID-19 Pandemic on Health Check-ups before and after the COVID-19 Downgrade and Employees' Mental Health at Health Check-up Facilities: The Third Nationwide Survey of Healthcare Facilities in Japan Society of Ningen Dock and Preventive Medical Care.
Satoko Yamaguchi, Tomofumi Atarashi, Akira Okada, Reiko Inoue, Shigeru Nasu, Yasuji Arase

JMA J· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral blood CD4+/CD8+ T cell ratio may have potential for predicting the treatment response of durvalumab plus tremelimumab therapy (STRIDE) for unresectable hepatocellular carcinoma: Preliminary report.
Yusuke Kawamura, Norio Akuta, Junichi Shindoh, Masaru Matsumura, Satoshi Okubo, Yasuji Arase

Hepatol Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis